Home » Topics » BioWorld Science

BioWorld Science
RSS

HIV protease inhibitor under evaluation at Pharmacia & Upjohn

Sep. 6, 1996

Antisense anti-HIV agent heading for clinical trials

Sep. 6, 1996

Virus susceptibility gene finally cloned

Sep. 6, 1996

Thalidomide effective in chronic erythema multiforme

Sep. 6, 1996

Bayer discloses antibacterial agents

Sep. 6, 1996

New antibiotics from Zeneca

Sep. 6, 1996

Carbapenems reported by Merck & Co.

Sep. 6, 1996

Merck & Co. describes antibiotics active against resistant staphylococci

Sep. 6, 1996

Japanese companies report cephems

Sep. 6, 1996

Allergen describes compounds with retinoid-like activity

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...